Since 2020, Lilly has invested more than $55 billion globally in building, expanding, and acquiring manufacturing facilities to support medicines for diabetes, obesity, Alzheimer’s disease, cancer, …
Eli Lilly to invest $1 billion in India for manufacturing and quality hub
view original post